Log in to save to my catalogue

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320010

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

About this item

Full title

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2015-02, Vol.21 (2), p.159-165

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Restriction of FXR agonism to the gut improves obesity and diabetes.
The systemic expression of the bile acid (BA) sensor farnesoid X receptor (FXR) has led to promising new therapies targeting cholesterol metabolism, triglyceride production, hepatic steatosis and biliary cholestasis. In contrast to systemic therapy, bile acid release during a m...

Alternative Titles

Full title

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320010

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320010

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.3760

How to access this item